GTPase HRas: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
No edit summary |
||
| (5 intermediate revisions by one other user not shown) | |||
| Line 19: | Line 19: | ||
The ''RAS'' gene family was discovered due to the presence of two closely related retroviral cancer genes (oncogenes) within the Harvey and Kirsten '''RA'''t '''S'''arcoma viruses. These retroviral oncogenes arose via capture of two normal cellular genes, ''H-RAS'' and ''K-RAS''. A [[DNA]] transfection assay for [[Oncogenes|oncogenes]] in human bladder cancer later identified the same ''H-RAS'' gene. Remarkably, the mutated oncogenic form of ''H-RAS'' differed from its normal counterpart by a single nucleotide change that caused a single amino acid substitution. Biochemical studies of purified RAS proteins revealed that they were capable of binding nucleotides, with a particularly high affinity for GTP. Extensive genetic, biochemical, and structural studies have established a model in which the RAS proteins function as molecular switches, as do related GTP-binding proteins. The RAS switch is "ON" when it binds <scene name='User:Joseph_Lipsick/RAS/Ras-gtp_switches/5'>GTP</scene>, and is "OFF" when it binds <scene name='User:Joseph_Lipsick/RAS/Ras-gdp_switches/11'>GDP</scene>. The changes in protein conformation between the <scene name='User:Joseph_Lipsick/RAS/Ras-gtp_switch_i_ii_spacefill/2'>"ON"</scene> and <scene name='User:Joseph_Lipsick/RAS/Ras-gdp_switch_i_ii_spacefill/3'>"OFF"</scene> states are not very large. These changes primarily occur in two regions known as SWITCH I (yellow) and SWITCH II (magenta), and can be visualized by toggling the spin off and on in these partial space-filling models. The RAS protein itself has an intrinsic GTPase activity, thereby limiting the duration of time spent in the "ON" configuration. The binding sites of the nucleotide and the magnesium ion are revealed in high detail and consists of a characteristic <scene name='5p21/Ligand_binding_site/1'>Walker motif</scene> (GXXXXGK[T/S]).<br /> For additional details on RAS see<br /> | The ''RAS'' gene family was discovered due to the presence of two closely related retroviral cancer genes (oncogenes) within the Harvey and Kirsten '''RA'''t '''S'''arcoma viruses. These retroviral oncogenes arose via capture of two normal cellular genes, ''H-RAS'' and ''K-RAS''. A [[DNA]] transfection assay for [[Oncogenes|oncogenes]] in human bladder cancer later identified the same ''H-RAS'' gene. Remarkably, the mutated oncogenic form of ''H-RAS'' differed from its normal counterpart by a single nucleotide change that caused a single amino acid substitution. Biochemical studies of purified RAS proteins revealed that they were capable of binding nucleotides, with a particularly high affinity for GTP. Extensive genetic, biochemical, and structural studies have established a model in which the RAS proteins function as molecular switches, as do related GTP-binding proteins. The RAS switch is "ON" when it binds <scene name='User:Joseph_Lipsick/RAS/Ras-gtp_switches/5'>GTP</scene>, and is "OFF" when it binds <scene name='User:Joseph_Lipsick/RAS/Ras-gdp_switches/11'>GDP</scene>. The changes in protein conformation between the <scene name='User:Joseph_Lipsick/RAS/Ras-gtp_switch_i_ii_spacefill/2'>"ON"</scene> and <scene name='User:Joseph_Lipsick/RAS/Ras-gdp_switch_i_ii_spacefill/3'>"OFF"</scene> states are not very large. These changes primarily occur in two regions known as SWITCH I (yellow) and SWITCH II (magenta), and can be visualized by toggling the spin off and on in these partial space-filling models. The RAS protein itself has an intrinsic GTPase activity, thereby limiting the duration of time spent in the "ON" configuration. The binding sites of the nucleotide and the magnesium ion are revealed in high detail and consists of a characteristic <scene name='5p21/Ligand_binding_site/1'>Walker motif</scene> (GXXXXGK[T/S]).<br /> For additional details on RAS see<br /> | ||
[[H-RasK117R mutant]]<br /> | [[H-RasK117R mutant]]<br /> | ||
[[Ras Protein and Pancreas Cancer]]<br /> | |||
[[User:Joseph Lipsick/RAS]]<br /> | [[User:Joseph Lipsick/RAS]]<br /> | ||
[[H RAS protein (hebrew)]]<br /> | |||
[[Chani elisha]]. | [[Chani elisha]]. | ||
| Line 28: | Line 30: | ||
== Structural highlights == | == Structural highlights == | ||
Interactions with the <scene name='37/379455/Cv/6'>nucleotide phosphate moiety in the active site</scene> of GTPase Hras determine its active conformation<ref>PMID:242356730</ref>. Water molecules shown as red spheres. | Interactions with the <scene name='37/379455/Cv/6'>nucleotide phosphate moiety in the active site</scene> of GTPase Hras determine its active conformation<ref>PMID:242356730</ref>. Water molecules shown as red spheres. <scene name='37/379455/Cv/7'>Mg coordination site</scene>. | ||
==3D structures of GTPase Hras== | |||
[[GTPase Hras 3D structures]] | |||
</StructureSection> | </StructureSection> | ||
==References== | ==References== | ||